FY2028 EPS Estimates for X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Raised by Analyst

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – HC Wainwright increased their FY2028 earnings estimates for shares of X4 Pharmaceuticals in a note issued to investors on Friday, August 9th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings per share of $0.38 for the year, up from their previous estimate […]

Leave a Reply

Your email address will not be published.

Previous post Q4 2025 EPS Estimates for Conduent Incorporated Boosted by Sidoti Csr (NASDAQ:CNDT)
Next post FY2026 EPS Estimates for BlackSky Technology Inc. Lowered by Sidoti Csr (NYSE:BKSY)